- €2.25bn
- €2.43bn
- €394.08m
- 74
- 10
- 70
- 49
Annual balance sheet for Exosens SAS, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 31.7 | 18.3 | 29 | 15.5 | 117 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 38.9 | 49.4 | 55.1 | 98.5 | 104 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 119 | 113 | 145 | 193 | 314 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 43.7 | 46.5 | 60.5 | 82.8 | 104 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 598 | 461 | 529 | 656 | 817 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 59 | 53.5 | 72.5 | 110 | 107 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 501 | 288 | 346 | 452 | 404 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 97.1 | 172 | 183 | 204 | 413 |
| Total Liabilities & Shareholders' Equity | 598 | 461 | 529 | 656 | 817 |
| Total Common Shares Outstanding |